SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-038599
Filing Date
2023-11-13
Accepted
2023-11-13 16:06:33
Documents
13
Period of Report
2023-11-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20231113.htm   iXBRL 8-K 25031
5 ardx-20231113_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-23-038599.txt   160597

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20231113.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20231113_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20231113_pre.xml EX-101.PRE 13046
7 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20231113_htm.xml XML 2795
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 231398657
SIC: 2834 Pharmaceutical Preparations